2008
DOI: 10.1210/jc.2007-2701
|View full text |Cite
|
Sign up to set email alerts
|

p.H62L, a Rare Mutation of the CYP21 Gene Identified in Two Forms of 21-Hydroxylase Deficiency

Abstract: According to phenotype and functional studies, p.H62L is a mild mutation, responsible for a more severe phenotype when associated with another mild mutation. These data are important for patient management and genetic counseling.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
27
0
4

Year Published

2008
2008
2021
2021

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 39 publications
(32 citation statements)
references
References 23 publications
1
27
0
4
Order By: Relevance
“…In vitro activity data revealed a synergistic effect of p.H62Lϩp.P453, which may explain the mild SV phenotype of the Scandinavian patients. Similar results on these mutations were published during revision of this paper (20). In summary, we describe five rare, including three novel CYP21A2 mutations causing 21OHD.…”
Section: Discussionsupporting
confidence: 84%
“…In vitro activity data revealed a synergistic effect of p.H62Lϩp.P453, which may explain the mild SV phenotype of the Scandinavian patients. Similar results on these mutations were published during revision of this paper (20). In summary, we describe five rare, including three novel CYP21A2 mutations causing 21OHD.…”
Section: Discussionsupporting
confidence: 84%
“…The majority (93.3%) presented abnormal 17-OHP values in relation to the normal reference values in the literature (40,43,44); moreover, if we plot these results on New's nomogram (45) 13 infants (86.7%) were in the range of heterozygotes, 1 in the range of patients with a non-classic form of CAH, and 1 in the range of unaffected infants. This normal result was found for a girl who was submitted to the Figure 1 Blood spot 17-OHP levels in the screening of three groups of newborns in relation to gestational age.…”
Section: Biochemical Findingsmentioning
confidence: 88%
“…The molecular study was performed according to a cascade strategy, permitting the exploration of the entire gene at the Endocrine and Molecular Biochemistry Laboratory of Debrousse Hospital, Lyon, France (40).…”
Section: Genetic Analysismentioning
confidence: 99%
“…CYP21A2 molecular analysis was prescribed by the referring endocrinologist and performed (by YM and VT-G) in the Molecular Laboratory for Rare Endocrine Disorders (Lyon, France), as previously reported (8,25,26).…”
Section: Molecular Analysis Of Cyp21a2mentioning
confidence: 99%